• Home
  • Medical Policy Update

Medical Policy Update

Blue Cross and Blue Shield of Kansas (BCBSKS) has published the following updated medical policies on the BCBSKS Website. Click on a link to view the details of each policy.

Published 12/29/22:​​​​​​

  • Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
  • Bone Mineral Density Studies
  • Diagnosis and Treatment of Sacroiliac Joint Pain
  • Drug Testing in Pain Management and Substance Use Disorder Treatment
  • Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus
  • Esophageal pH Monitoring
  • Facet Joint Denervation
  • Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
  • Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
  • Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders
  • Measurement of Serum Antibodies to Selected Biologic Agents
  • Monitored Anesthesia Care
  • Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease
  • Proteomic Testing for Systemic Therapy in Non-Small-Cell Lung Cancer
  • Sphenopalatine Ganglion Block for Headache
  • Transcranial Magnetic Stimulation (TMS) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders

If you have questions regarding this publication, please contact your BCBSKS provider consultant/representative.

Institutional Providers
Professional Providers